A machine learning approach to predict the parameters of COVID‐19 severity to improve the diagnosis protocol in Oman
Tóm tắt
The purpose of this study is to utilize a Machine Learning-based methodology for predicting the key parameters contributing to severe COVID-19 cases among patients in Oman. To carry out the investigation, a comprehensive dataset of patient information, encompassing a range of blood parameters, was acquired from major government hospitals in Oman. Diverse machine learning algorithms were deployed to uncover underlying trends within the acquired dataset. The outcomes of this research delineated the determinants of severe cases into two categories: non-blood-related parameters and blood-related parameters. Among non-blood-related factors, advanced age, gender, and the presence of chronic kidney disease emerged as risk factors contributing to unfavorable prognoses, particularly in elderly patients. In the realm of blood parameters, male patients with blood types O-positive and A-positive exhibited heightened susceptibility to severe illness compared to their female counterparts. Additionally, deviations in Hemoglobin levels, Mean Cell Volume, and Eosinophil counts were identified as drivers of poor prognoses among elderly patients. The implications of these research findings extend to aiding healthcare decision-makers in quantifying the associated risks, health benefits, and cost-effectiveness pertaining to COVID-19. Furthermore, the acquired insights can empower decision-makers to refine the management of COVID-19, expediting treatment protocols and minimizing the risk of mortality. Interestingly, the study unveiled a correlation linking blood type to disease progression. A notable finding indicated that a staggering 96.5% of patients succumbed to the disease even when their blood sodium levels remained in the standard range of 136–145 mmol/L. These insights hold immense value for healthcare institution decision-makers, allowing a more in-depth evaluation of the risks, health benefits, and the cost-effectiveness related to COVID-19. Consequently, the findings offer a guiding light for implementing pivotal measures, optimizing treatment protocols, and substantially reducing mortality risks associated with the virus.
Tài liệu tham khảo
Chatterjee S (2021) COVID-19: tackling global pandemics through scientific and social tools. Academic Press, Cambridge
Nanda A, Tuteja S, Gupta S (2022) Machine learning based analysis and prediction of college students’ mental health during COVID-19 in India. Elsevier, Amsterdam
Dashboard W C (2023) WHO Coronavirus (COVID-19) Dashboard.
Ryalat MH, Dorgham O, Tedmori S, Al-Rahamneh Z, Al-Najdawi N, Mirjalili S (2023) Harris hawks optimization for COVID-19 diagnosis based on multi-threshold image segmentation. Neural Comput & Applic 35:6855–6873
Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, Wooster L, Rotter JI, Guo X, Malhotra R (2020) Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Med Virol 92:10
Dilsizian SE, Siegel EL (2014) Artificial intelligence in medicine and cardiac imaging: harnessing big data and advanced computing to provide personalized medical diagnosis and treatment. Curr Cardiol Rep 16:441
Obermeyer Z, Emanuel EJ (2016) Predicting the future - big data, machine learning, and clinical medicine. N Engl J Med 375:13
Zhang B, Nilsson ME, Prigerson HG (2012) Factors important to patients’ quality of life at the end of life. Arch Intern Med. 172(15):1133–1142
Rumaling MI, Chee FP, Bade A, Goh LPW, Juhim F (2023) Biofingerprint detection of corona virus using Raman spectroscopy: a novel approach. SN Appl Sci 5:197
Altan A, Karasu S (2020) Recognition of COVID-19 disease from X-ray images by hybrid model consisting of 2D curvelet transform, chaotic salp swarm algorithm and deep learning technique. Chaos Solitons Fractals 140:110071
Khanday AMUD, Rabani ST, Khan QR, Rouf N, Mohi UDM (2020) Machine learning based approaches for detecting COVID-19 using clinical text data. Int J Inf Technol 12:3
Al Wahaibi A, Al Rawahi B, Patel PK, AlKhalili S, AlMaani A, Al-Abri S (2021) COVID-19 disease severity and mortality determinants: a large population-based analysis in Oman. Travel Med Infect Dis 39:101923
CDC COVID-19 Response team (2020) Severe outcomes among patients with coronavirus disease 2019 (COVID-19) In: Proceedings of the MMWR Morb Mortal Wkly Rep (United States, 16 Feb 12-March 2020)
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan. China Descriptive Study 15(395):507–513
MOH (2020) Analysis COVID-19 gene sequencing
UK Health Security Agency SARS-CoV-2 variants of concern and variants under investigation in England. . Technical Briefing 35: UKHSA 2022
Union, A. a. o. t. E. European centre for disease prevention and control. 2023
Yan B, Zhang X, Wu L, Zhu H, Chen B (2020) Why do countries respond differently to COVID-19 A comparative study of Sweden, China, France, and Japan. Am Rev Public Adm 50(6–7):762–769
NIH (2021) How COVID-19 variants evade immune response. National Institues of health research matters. NIH, Bethesda
Pavia C, Gurtler V (2022) Covid-19: biomedical perspectives. Elsevier, Amsterdam
WHO (2021) Coronavirus disease (COVID-19). WHO, Geneva
Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8(4):21
Selvin E, Juraschek SP (2020) Diabetes epidemiology in the COVID-19 pandemic. Diabetes Care 43(8):1690–1694
Long JB, Ehrenfeld JM (2020) The role of augmented intelligence (AI) in detecting and preventing the spread of novel coronavirus. J Med Syst 44:3
Jain S, Pandey K, Jain P, Seng KP (2022) Artificial intelligence, machine learning, and mental health in pandemics: a computational approach. Elsevier, Amsterdam
Tayarani N, Mohammad H (2021) Applications of artificial intelligence in battling against covid-19: a literature review. Chaos Solitons Fractals 142:110338
Vaishya R, Javaid M, Khan IH, Haleem A (2020) Artificial intelligence (ai) applications for covid-19 pandemic. Diabetes Metab Syndr 14(4):337–339
Hevner AR, March ST, Park J, Ram S (2004) Design science in information systems research. MIS Quart 28(1):75–105
Shang W, Dong J, Ren Y, Tian M, Li W, Hu J, Li Y (2020) The value of clinical parameters in predicting the severity of COVID-19. J Med Virol 92(10):2188–2192
Georges H, Brogly N, Olive D, Leroy O (2010) Thrombocytosis in patients with severe community-acquired pneumonia. Chest J 138:5
Masana L, Correig E, Ibarretxe D, Anoro E, Arroyo JA, Jericó C, Guerrero C, Miret ML, Näf S, Pardo A, Perea V (2021) Low HDL and high triglycerides predict COVID-19 severity. Sci Rep 11(7217):2021
Statsenko Y, Zahmi FA, Habuza T, Gorkom KN-V, Zaki N (2021) Prediction of COVID-19 severity using laboratory findings on admission: informative values, thresholds ML model performance. BMJ Open 11:2
Aktar S, Ahamad MM, Rashed-Al-Mahfuz M, Azad AK, Uddin S, Kamal AH, Alyami SA, Lin PI, Islam SM, Quinn JM, Eapen V (2021) Machine learning approach to predicting COVID-19 disease severity based on clinical blood test data: statistical analysis and model development. JMIR Med Inform 9(4):e25884
Asghar MS, Khan NA, Kazmi SJH, Ahmed A, Hassan M (2020) Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis. J Commun Hosp Internal Med Perspect 10:6
Seyit M, Avci E, Nar R, Senol H, Yilmaz A, Ozen M, Oskay A, Aybek H (2021) Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19. Am J Emerg Med 40:110–114
Yadav M, Perumal M, Srinivas M (2020) Analysis on novel coronavirus (COVID-19) using machine learning methods. Chaos Solitons Fractals 139:110050
Khalifa NEM, Taha MHN, Manogaran G, Loey M (2020) A deep learning model and machine learning methods for the classification of potential coronavirus treatments on a single human cell. J Nanoparticle Res 22:11
Wu J, Zhang P, Zhang L, Meng W, Li J, Tong C, Li Y, Cai J, Yang Z, Zhu J, Zhao M, Huang H, Xie X, Li S (2020) Rapid and accurate identification of COVID-19 infection through machine learning based on clinical available blood test results. medRxiv. https://doi.org/10.1101/2020.04.02.20051136
Usul E, Şan İ, Bekgöz B, Şahin A (2020) Role of hematological parameters in COVID-19 patients in the emergency room. Biomarkers Med 14(13):1207–1215
Debuse J, de la Iglesia B, Howard C, Rayward-Smith V (2001) Building the KDD roadmap. Springer, London
Debuse JC, De la Iglesia B, Howard CM, Rayward-Smith VJ (2000) Building the KDD roadmap: a methodology for knowledge discovery. In: Roy R (ed) Industrial knowledge management. Springer-Verlag, London, pp 179–196
Williams G.J. and Z., H. A case study in knowledge acquisition for insurance risk assessment using a KDD methodology. Dept. of AI, Univ. of NSW, 1996.
Rahman F.A., Desa M.I., A., W. and Haris N.A. Knowledge discovery database (KDD)-data mining application in transportation. Proceeding of the Electrical Engineering Computer Science and Informatics, 1, 1 (2014), 116–119.
Huang Z (1998) Extensions to the k-Means Algorithm for Clustering Large Data Sets with Categorical Values. Data Min Knowl Disc 2(3):283–304
Khan S. and Kant S. Computation of Initial Modes for K-modes Clustering Algorithm using Evidence Accumulation. Morgan Kaufmann Publishers Inc., 2007.
He Z, Deng S, Xu X (2006) Approximation Algorithms for K-Modes Clustering. Springer, Berlin / Heidelberg
Z., H., Xu X., Deng S. and Deng S. K-Histograms: An Efficient Clustering Algorithm for Categorical Dataset. arXiv preprint cs/0509033 (2005).
He Z, Xu X, Deng S (2005) TCSOM: Clustering Transactions Using Self-Organizing Map. Neural Process Lett 22(3):249–262
Aranganayagi S, Thangavel K (2009) Improved K-Modes for Categorical Clustering Using Weighted Dissimilarity Measure. Int J Comput Intell 5:2
He Z, Xu X, Deng S (2005) Scalable Algorithms for Clustering Large Datasets with Mixed Type Attributes. Int J Intell Syst 20:10
Gionis A, Mannila H, Tsaparas P (2007) Clustering aggregation. ACM Trans Know Dis Data (TKDD). https://doi.org/10.1145/1217299.1217300
Al-Riyami AZ, Al-Marhoobi A, Al-Hosni S, Mahrooqi SA, Schmidt M, O’Brien S, Al-Khabori M (2019) Prevalence of red blood cell major blood group antigens and phenotypes among omani blood donors. Oman Med J 34(6):496
Sun L (2020) Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19. J Clin Virol. https://doi.org/10.1016/j.jcv.2020.104431
Bergamaschi G, Borrelli de Andreis F, Aronico N (2021) Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin Exp Med. https://doi.org/10.1007/s10238-021-00699-8
Zietz M, Zucker J, Zucker J, Tatonetti NP (2020) and Tatonetti NP Associations between blood type and COVID-19 infection, intubation, and death. Nat Commun 11:5761
Anurag A, Jha PK, Kumar A (2020) Differential white blood cell count in the COVID-19: a cross-sectional study of 148 patients. Diabetes Metab Syndr 14:2099–2102
Lindsley AW, Schwartz JT, Rothenberg ME (2020) Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol 146:1–7
Soni M (2020) Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection. Int J Lab Hematol. https://doi.org/10.1111/ijlh.13573
Latz CA, DeCarlo C, Boitano L, Png CYM, Patell R, Conrad MF, Eagleton M, Dua A (2020) Blood type and outcomes in patients with COVID-19. Ann Hematol 99(9):2113–2118
Sun L, Song F, Shi N, Liu F, Li S, Li P, Zhang W, Jiang X, Zhang Y, Sun L, Chen X, Shi Y (2020) Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19. J Clin Virol. https://doi.org/10.1016/j.jcv.2020.104431